Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression [0.03%]
索拉非尼治疗进展期肝细胞癌患者的生存分析
Leonidas Apostolidis,Jan Pfeiffenberger,Daniel Gotthardt et al.
Leonidas Apostolidis et al.
Background/aim: Sorafenib leads to improved survival in advanced hepatocellular carcinoma (HCC) patients. Continuation of sorafenib beyond progression has been a possible treatment strategy when further approved therapeut...
Intraplatelet Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor: New Biomarkers in Carcinoembryonic Antigen-Negative Colorectal Cancer? [0.03%]
血小板内血管内皮生长因子和血小板衍生生长因子： carcino胚胎抗原阴性的结直肠癌的新生物标志物？
Charbel Chater,Anne Bauters,Claire Beugnet et al.
Charbel Chater et al.
Background/aim: Colorectal cancer (CRC) is associated with high incidence and mortality rates. Carcinoembryonic antigen (CEA), a prognostic biomarker for recurrent CRC following curative resection, suffers from low sensit...
Network Meta-Analysis of Adjuvant Chemotherapy following Resection of Colorectal Liver Metastases [0.03%]
辅助性化疗术后肝转移的网络 meta 分析
Paschalis Gavriilidis,Aurelio Tobias,Robert P Sutcliffe et al.
Paschalis Gavriilidis et al.
Objective: Six principal adjuvant chemotherapy treatments (ACTs) are currently available for patients with resected colorectal liver metastases. This meta-analysis was designed to determine the optimal ACT, as evaluated b...
Beyond the Beyond: A Case of an Extraordinary Response to Multiple Lines of Therapy in a de novo Metastatic HER2-Negative Gastric Cancer Patient [0.03%]
超越极限：一例初发转移性HER2阴性胃癌患者对多种治疗方案产生非凡反应的病例报告
Cinzia Baldessari,Fabio Gelsomino,Andrea Spallanzani et al.
Cinzia Baldessari et al.
Background: Gastric cancer is the fourth cause of cancer-related death in Europe and the prognosis of these patients remains dismal. It has been demonstrated that chemotherapy improved survival compared with best supporti...
Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing? [0.03%]
胃癌中的糖类抗原19-9、癌胚抗原和糖类抗原72-4：老指标是否依然有效？
Andrey Iskrenov Kotzev,Peter Vassilev Draganov
Andrey Iskrenov Kotzev
Background: Gastric cancer (GC) is characterized by aggressive behavior and a high mortality rate. The diagnosis of GC is challenging because the GC is often diagnosed in an advanced stage. The use of tumor markers is a p...
[This corrects the article DOI: 10.1159/000442831.].
Published Erratum
Gastrointestinal tumors. 2018 Feb;4(3-4):104. DOI:10.1159/000479081 2018
Waiting Time following Neoadjuvant Chemoradiotherapy for Rectal Cancer: Does It Really Matter [0.03%]
新辅助放化疗后等待时间对直肠癌的意义真的重要吗？
Aris Plastiras,Michail Sideris,Andy Gaya et al.
Aris Plastiras et al.
Background: Neoadjuvant chemoradiotherapy (CRT) is considered the standard approach before any surgical intervention for locally advanced rectal tumors and has been proven to significantly improve the local recurrence rat...
Frederick H Koh,Aaron Seah,Dedrick Chan et al.
Frederick H Koh et al.
Background/aims: While colonoscopy is indicated in patients >50 years old presenting with hematochezia, its role in those ≤50 remains debatable. This study aims to evaluate the role of colonoscopy in patients presenting ...
Ryoichi Miyamoto,Yukio Oshiro,Ken Nakayama et al.
Ryoichi Miyamoto et al.
Background/aims: Anatomical variations are frequently encountered during hepato-biliary-pancreatic surgeries, requiring surgeons to have a precise understanding of the surgical anatomy in order to perform a safe surgery. ...
Short-Term Outcomes of Extended Pancreatectomy: A Single-Surgeon Experience [0.03%]
扩大胰腺切除术的短期结果：单个外科医生的经验
Tze-Yi Low,Ye-Xin Koh,Jin-Yao Teo et al.
Tze-Yi Low et al.
Background/aims: The International Study Group of Pancreatic Surgery recently published a consensus statement on the definition of extended pancreatectomy (EP). We aimed to determine the safety profile and short-term outc...